We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Allergan plc | NYSE:AGN | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
From Apr 2019 to Apr 2024
Hot Features
Premium
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 10(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 67,324,994 4.54142%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 67,324,994 4.54142%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 400 87.53
-------------- ----------------------------- -----------------------
Purchase 700 87.53
-------------- ----------------------------- -----------------------
Purchase 1,000 87.53
-------------- ----------------------------- -----------------------
Purchase 1,800 87.53
-------------- ----------------------------- -----------------------
Purchase 900 87.53
-------------- ----------------------------- -----------------------
Purchase 400 87.53
-------------- ----------------------------- -----------------------
Purchase 300 87.53
-------------- ----------------------------- -----------------------
Purchase 1,200 87.53
-------------- ----------------------------- -----------------------
Purchase 2,000 87.53
-------------- ----------------------------- -----------------------
Purchase 400 87.53
-------------- ----------------------------- -----------------------
Purchase 1,900 87.53
-------------- ----------------------------- -----------------------
Purchase 700 87.53
-------------- ----------------------------- -----------------------
Purchase 900 87.53
-------------- ----------------------------- -----------------------
Purchase 400 87.53
-------------- ----------------------------- -----------------------
Purchase 200 87.53
-------------- ----------------------------- -----------------------
Purchase 594 87.53
-------------- ----------------------------- -----------------------
Purchase 185,801 87.53
-------------- ----------------------------- -----------------------
Purchase 51,818 87.53
-------------- ----------------------------- -----------------------
Purchase 17,898 87.53
-------------- ----------------------------- -----------------------
Purchase 1,050 87.53
-------------- ----------------------------- -----------------------
Purchase 420 87.53
-------------- ----------------------------- -----------------------
Purchase 4,800 87.76
-------------- ----------------------------- -----------------------
Purchase 2,800 84.77
-------------- ----------------------------- -----------------------
Purchase 50 87.51
-------------- ----------------------------- -----------------------
Purchase 300 87.53
-------------- ----------------------------- -----------------------
Purchase 532 87.53
-------------- ----------------------------- -----------------------
Purchase 976 87.53
-------------- ----------------------------- -----------------------
Purchase 114 84.73
-------------- ----------------------------- -----------------------
Purchase 200 87.53
-------------- ----------------------------- -----------------------
Purchase 185 87.53
-------------- ----------------------------- -----------------------
Sale 79,700 87.51
-------------- ----------------------------- -----------------------
Sale 400 87.53
-------------- ----------------------------- -----------------------
Sale 96 87.53
-------------- ----------------------------- -----------------------
Sale 900 87.53
-------------- ----------------------------- -----------------------
Sale 1,900 87.53
-------------- ----------------------------- -----------------------
Sale 400 87.53
-------------- ----------------------------- -----------------------
Sale 700 87.53
-------------- ----------------------------- -----------------------
Sale 300 87.53
-------------- ----------------------------- -----------------------
Sale 1,200 87.53
-------------- ----------------------------- -----------------------
Sale 400 87.53
-------------- ----------------------------- -----------------------
Sale 300 87.53
-------------- ----------------------------- -----------------------
Sale 700 87.53
-------------- ----------------------------- -----------------------
Sale 100 84.73
-------------- ----------------------------- -----------------------
Sale 200 87.53
-------------- ----------------------------- -----------------------
Sale 87,122 87.53
-------------- ----------------------------- -----------------------
Sale 1,276 87.53
-------------- ----------------------------- -----------------------
Sale 2,328 87.53
-------------- ----------------------------- -----------------------
Sale 8,478 87.53
-------------- ----------------------------- -----------------------
Sale 13,871 87.53
-------------- ----------------------------- -----------------------
Sale 400 86.58
-------------- ----------------------------- -----------------------
Sale 195 87.53
-------------- ----------------------------- -----------------------
Sale 538 87.53
-------------- ----------------------------- -----------------------
Sale 538 87.53
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 11(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 11, 2020 10:46 ET (14:46 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
